amoxicillin-potassium-clavulanate-combination and Respiratory-Distress-Syndrome

Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Azithromycin; Betacoronavirus; Chloroquine; Combined Modality Therapy; Coronavirus Infections; COVID-19; Fatal Outcome; Female; Humans; Infant; Morocco; Multiple Organ Failure; Nasopharynx; Pandemics; Pneumonia, Viral; Respiration, Artificial; Respiratory Distress Syndrome; SARS-CoV-2; Tomography, X-Ray Computed

Slackia exigua (S. exigua) is an obligatory anaerobic coccobacillus under the family of Coriobacteriaceae. It is a rare cause of pyogenic extraoral infections. We report a 58-year-old lady with good past health presented with fulminant community-acquired pneumonia causing acute respiratory distress syndrome caused by S. exigua requiring veno-venous extra-corporeal membrane oxygenation (VV-ECMO). Bacterial identification can be challenging and often require 16 S rRNA and MALDI-TOF MS. The patient was treated with amoxicillin-clavulanic acid according to sensitivity and made significant recovery.

Topics: Actinobacteria; Amoxicillin-Potassium Clavulanate Combination; Community-Acquired Infections; Empyema; Extracorporeal Membrane Oxygenation; Female; Gram-Positive Bacterial Infections; Humans; Middle Aged; Pneumonia; Respiratory Distress Syndrome; Treatment Outcome

Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Doxycycline; Drug Therapy, Combination; Female; Fever; Humans; Middle Aged; Pasteurella Infections; Pasteurella multocida; Postoperative Complications; Respiration, Artificial; Respiratory Distress Syndrome